[1]Zhao B, Li L, Lei Q Y, Guan K L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes and Development, 2010, 24: 862-874.[2]Sudol M, Harvey K F. Modularity in the Hippo signaling pathway. Trends in Biochemical Sciences, 2010, 35(11): 627-633.[3]Yin M X, Zhang L. Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance. Journal of Genetics and Genomics, 2011, 38: 471-481.[4]周洲, 朱金水. Hippo 通路及YAP基因研究的新进展. 现代肿瘤医学, 2011, 19(6): 1241-1244.Zhou Z, Zhu J S. Research advances on Hippo signal pathway and YAP gene. Modern Oncology, 2011, 19(6): 1241-1244.(in Chinese)[5]Zhang J M, Ji J Y, Yu M, Overholtzer M, Smolen G A, Wang R, Brugge J S, Dyson N J, Haber D A. YAP-dependent induction of am-phiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nature Cell Biology, 2009, 11(12): 1444-1450.[6]李宁, 肖虹, 郑绘霞, 万慧丽, 赵玉泽, 梁建芳. YAP蛋白在膀胱尿路上皮肿瘤中的表达及临床意义. 山西医科大学学报, 2011, 42(5): 383-386.Li N, Xiao H, Zheng H X, Wan H L, Zhao Y Z, Liang J F. The expression of Yes-associated protein in urothelial tumors of bladder and its clinical significance. Journal of Shanxi Medicine University, 2011, 42(5): 383-386. (in Chinese)[7]张靖, 朱金水. Hippo-YAP信号通路与胃癌相关性研究. 国际消化病杂志, 2011, 31(4): 207-215.Zhang J, Zhu J S. Research on the relationship between Hippo-YAP signaling pathway and gastric cancer. International Journal of Digestive Diseases, 2011, 31(4): 207-215.(in Chinese)[8]赵修民, 王德林.YAP基因表达与肿瘤的关系. 广东医学, 2011, 32(12): 1628-1629.Zhao X M, Wang D L. Research on the relationship between the expression of YAP and tumor. GuangDong Medical Journal, 2011, 32(12): 1628-1629.(in Chinese)[9]刘丛丛, 梁建芳, 郑绘霞, 肖虹, 李宁, 程彩霞, 王宏坤, 武丽娜, 张民, 赵玉泽. YAP在结直肠腺癌组织中的表达及意义. 中国药物与临床, 2011, 11(1): 23-26.Liu C C, Liang J F, Zheng H X, Xiao H, Li N, Cheng C X, Wang H K, Wu L N, Zhang M, Zhao Y Z. Expression and clinical significance of YAP in colorectal adenocarcinoma. Chinese Remedies and Clinics, 2011, 11(1): 23-26.(in Chinese)[10]刘玉, 夏立平, 郑武平. YAP在乳腺癌中的表达及其临床意义. 海南医学院学报, 2010, 16(6): 699-704.Liu Y, Xia L P, Zheng W P. Expression and clinical significance of YAP in breast carcinoma tissues. Journal of Hainan Medical University, 2010, 16(6): 699-704.(in Chinese)[11]Zhao B, Lei Q Y, Guan K L.The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Current Opinion in Cell Biology, 2008, 20: 638-646.[12]Yeku O, Frohman M A. Rapid Amplification of cDNA Ends (RACE). Methods in Molecular Biology, 2011, 703(1): 107-122.[13]Yokoyama T, Osada H, Murakami H, Tatematsu Y, Taniguchi T, Kondo Y, Yatabe Y, Hasegawa Y, Shimokata K, Horio Y, Hida T, Sekido Y. YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. Carcinogenesis, 2008, 29(11): 2139-2146.[14]Yagi R, Chen L F, Shigesada K, Murakami Y, Yoshiakilto. A WW domain-containing Yes-associated protein(YAP) is a novel transcriptional co-activator. The EMBO Journal, 1999, 18(9): 2551-2562.[15]Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes protooncogene product. Oncogene, 1994, 9: 2145-2152.[16]Garnier L, Wills J W, Verderame M F, Sudol M. WW domains and retroviral budding. Nature, 1996, 381: 744-745.[17]Wang K, Degerny C, Xu M, Yang X J. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochemistry and Cell Biology, 2009, 87 : 77-91.[18]Basu S, Totty N F, Irwin M S, Sudol M, Downward J, Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Molecular Cell, 2003, 11: 11-23.[19]Zhao B, Ye X, Yu J, Li L, Li W, Li S, Lin J D, Wang C Y, Chinnaiyan A M, Lai Z C, Guan K L. TEAD mediates YAP-dependent gene induction and growth control. Genes & Development, 2008, 22: 1962-1971.[20]Camargo F D, Gokhale S, Johnnidis J B, Fu D, Bell G W, Jaenisch R, Brummelkamp T R. YAP1 increases organ size and expands undifferentiated progenitor cells. Current Biology, 2007, 17: 2054-2060.[21].Watt K I, Judson R, Medlow P, Reid K, Kurth T B, Burniston J G, Ratkevicius A, Bari C D, Wackerhage H. Yap is a novel regulator of C2C12 myogenesis. Biochemical and Biophysical Research Communications, 2010, 393: 619-624.[22]Gise A V, Lin Z Q, Schlegelmilch K, Honor L B, Pan G M, Buck J N, Ma Q, Ishiwata T, Zhou B, Camargo F D, Pu W T. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proceedings of the National Academy of Sciences, 2012, 109(7): 2394-2399.[23].Schlegelmich K, Mohseni M, Kirak O, Pruszak J, Renato J, Rodriguez, Zhou D W, Kreger B T, Vasioukhin V, Avruch J, Brummelkamp T R, Camargo F D. Yap1 act downstream of α-Catenin to control epidermal proliferation. Cell, 2011, 144 (5): 782-795.[24].Camargo F D, Gokhale S, Johnnidis J B, Fu D D, Bell G W, Jaenisch R, Brummelkamp T R. YAP1 increases organ size and expands undifferentiated progenitor cells. Current Biology, 2007, 17(23): 2054-2060.[25]Wang W Q, Huang J, Chen J J. Angiomotin-like Proteins Associate with and negatively regulate YAP1. Journal of Biological Chemistry, 2010, 286: 4364-4370.[26]Fernandez-L A, Northcott P A, Dalton J, Fraga C, Ellison D, Angers S, Taylor M D, Kenney A M. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Current Issue, 2009, 23: 2729-2741. |